$BUD, $ADM, $CG, $FENC, $INTU
Below is a list of Wall Street’s Top analysts outlook for Key issues for Tuesday, as follows:
Anheuser-Busch InBev S.A./N.V. (NYSE:BUD) was raised to Outperform from Market Perform with a 132 price target at Bernstein.
Carlyle Group L.P. (NASDAQ:CG) was raised to Buy from Neutral with a 28.50 price target at Citigroup.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) was started as Outperform with a 17 price target at Wedbush Securities. The firm noted that Pedmark is the 1st compound shown to prevent hearing loss in children, and it expects approval in mid-to-late Y 2019 in the United States and European Union, with peak sales potential of $225-M in those 2 regions
Intuit Inc. (NASDAQ:INTU) was reiterated as Outperform and the price target was raised to 195 from 185 at Credit Suisse, with the firm talking up Q-3 results and recent IRS tax filings data.
Latest posts by Paul Ebeling (see all)
- The Link Between Food and Mood - March 17, 2018
- Gem Diamonds Ltd (OTCMKT:GMDMF) Sold the Lesotho Legend for $40-M - March 17, 2018
- No Wall Street Analysts are Championing Bitcoin - March 17, 2018